groups of monkeys at an interval of 4 to 7 days, and they, together with controls, were challenged 10 days after the last dose with one or another of the virulent parent dysentery strains. A significant degree of protection was afforded in all vaccinated groups with the exception of one group challenged with S. flexneri 6, a component not included in the vaccine. When animals were challenged with virulent S. flexneri 2a 1 month after oral vaccination, they were also protected. The vaccine produced a rise in serum antibody, but we were not able to detect coproantibody in saline extracts of feces from animals which received the vaccine.
We previously have shown that a strain of Shigella flexneri 2a lost its capacity to cause a fatal enteric infection in starved guinea pigs when, by recombination, it incorporated into its genome the genetic material between the rhamnose-xylose region of an Hfr strain of Escherichia coli (1) . Such a hybrid strain retained its ability to invade tissue, but appeared to be unable to multiply in the intestinal mucosa (2) . A single oral dose of 5 X 1010 cells of the hybrid strain sufficed to render monkeys resistant to experimental oral challenge with the virulent parent strain of S. flexneri 2a (3) .
There are over 30 different serotypes of dysentery bacilli, and it is not at all certain whether hybrid strains of others would possess properties similar to those of our S. flexneri 2a hybrid strain. The purpose of this communication is to describe the characteristics of hybrid strains of S. flexneri lb, S. flexneri 3, and S. sonnei I, and to present the results of studies in which a livng polyvalent oral vaccine was used to protect monkeys against experimental challenge.
MATERIALS AND METHODS
Cultures. S. flexneri lb strain 1Z, S. flexneri 2a strain 2457T, S. flexneri 3 strain J17B, S. flexneri 6 strain CCH060, and S. sonnei I strain 53G were all isolated from human beings with bacillary dysentery. Escherichia coli Hfr strain W1895 and E. coli-S. flexneri 2a hybrid strain X16 have been described previously (2, 3; Formal et al., in press).
Mating procedures. The methods used to obtain E. coli-Shigella hybrid strains were similar to those already described (1, 2) .
Biological tests. Tests for the ability of the various strains to invade HeLa cells, to produce keratoconjunctivitis, to fatally infect guinea pigs, to multiply in the small intestine of the starved guinea pig, to cause dysentery in monkeys, and to protect monkeys against experimental challenge have been described previously (2, 3, 4) .
Serological tests. The passive hemagglutination test was used to detect serum and coproantibody 17 FORMAL ET AL. levels. The methods employed have been described (Formal et al., in press). In the present study, the procedure for coporantibody determinations was modified to the extent that the stool extracts were diluted in 15% human serum albumin instead of saline.
RESULTS
Genetic studies. S. flexneri lb strain 1Z, S. flexneri 3 strain J17B, and S. sonnei I strain 53G
were mated with Hfr E. coli K-12 strain W1895 and plated on minimal medium containing xylose but lacking methionine. Clones from the E. coli-Shigella matings were purified, and their biochemical patterns were determined. After preliminary testing, a single hybrid strain from each mating was selected for further studies. The genetic characteristics of the parent and hybrid strains are presented in Table 1 .
Studies in guinea pigs. The ability of the hybrids and wild-type shigellae to cause a fatal enteric infection in starved guinea pigs is compared in Table 2 . The virulence of the hybrids was markedly reduced in each case. By use of the fluorescent-antibody technique, each of the hybrid strains was shown to retain the property of being able to penetrate the intestinal epithelium and to reach the lamina propria. This resulted in a mild acute inflammatory reaction in the ileal mucosa. The ability of the parent and hybrid strains to grow in the small intestine of the experimentally infected guinea pig was next compared. The parent strains remained in the small intestine in large numbers over the course of the experiment, whereas the hybrids were rapidly cleared from the small intestine (Fig. 1) Reactions in monkeys. A single dose consisting of 5 X 10'°cells (grown on BHI Agar) suspended in 20 ml of BHI broth was fed to groups of eight monkeys, and the animals were observed for 1 week. None of the animals developed diarrhea or dysentery. Similar preparations were administered to groups of five or six monkeys; these animals were killed and autopsied 48 hr after challenge. No gross changes were seen in the colon or other organs. The only abnormality noted microscopically consisted of a very mild, patchy colitis with polymorphonuclear leukocytes in the lamina propria and a few scattered crypt abscesses.
Polyvalent vaccine studies. A polyvalent vaccine consisting of hybrid S. flexneri lb strain 1Z x 13, S. flexneri 2a strain M22-18 X 16 (2, 3, Formal et al., in press), S. flexneri 3 strain J17B x 19, and S. sonnei I strain 53G X 7 was tested for its ability to protect monkeys against experimental challenge. Two doses of this vaccine were fed at intervals of 4 to 7 days; a dose consisted of 2 x 1010 viable cells of each of the component strains suspended in 20 ml of BHI broth. Of 212 animals which received the polyvalent vaccine, 29 had diarrhea. The diarrhea usually occurred after the first vaccine dose, and stools usually returned to normal within the next 24 hr.
Shedding of the vaccine strains after oral feeding differed from monkey to monkey. From some animals, we failed to isolate the vaccine strain after its administration. It may be noted here that these animals still responded with a rise in serum antibody levels (see below). Some animals shed one or another of the component strains, and others shed two, three, or all of the hybrids. In most cases, the components were isolated for no longer than 4 days after the last vaccine dose; however, an occasional animal intermittently excreted a hybrid strain for longer periods.
The passive hemagglutination test was used to determine the serum antibody titer in a total of 38 animals. Serum specimens were obtained before and 5 days after the last vaccine dose. All of the animals responded to one or another of the vaccine components with fourfold or greater rises in serum antibody titers. In most cases, rises in titer to all components were observed. In those instances where responses were not detected, the preimmunization antibody level was usually high. The pattern of this response is summarized in Table 3 .
Coproantibody studies were carried out on 11 Table 4 . In each instance, the monkeys receiving the vaccine experienced significantly less shigellosis than those animals in the control group. The symptoms in the vaccinated monkeys, when they were observed, tended to be milder than those in the control group, and often consisted of a single diarrheal stool. Only 3 cases of classical dysentery (diarrheal stool with blood and mucus) occurred in the vaccinated monkeys, whereas 35 control animals exhibited this syndrome. None of the animals receiving the vaccine died after the challenge. Eight control monkeys succumbed. It should be noted that in most instances the monkeys were treated with antibiotics whenever blood was observed in the stools. In the experiment where deaths were observed, treatment was withheld from both the vaccinated and control animals. In one experiment, the animals were challenged with S. flexneri 6, which was not a component of the vaccine. There was no evidence of protection.
Two experiments were conducted in which vaccinated and control monkeys were challenged with S. flexneri 2a 1 month after the vaccine group received its last dose. In the first experiment, the vaccine was monovalent and consisted of 5 X 10'°cells per dose of the hybrid strain of S. flexneri 2a; in the second experiment, the polyvalent vaccine was used. The results indicate that the animals were still protected 1 month after vaccination (Table 5 ). All animals which developed bloody stools in these two experiments were given antibiotic therapy; however, treatment was not started soon enough to save four of the control animals which died in the second experiment.
DIscussioN
In previous studies, we demonstrated that the virulence of a single strain of S. flexneri 2a was markedly reduced for starved guinea pigs and monkeys after acquisition by mating of genetic material between the rha+-xyl4 region of the E. coli K-12 genome (1) . The The animals were fed two doses of the vaccine 7 days apart.
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